Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study
Clinical trial NCT05948891 · UNKNOWN
Trial details
- NCT number
- NCT05948891
- Sponsor
- Chiesi SAS
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.